(from hit findings to IND), to discover & evaluate the therapies of tomorrow together
Since the inception of the company, Oncodesign Services has been pioneering in translational pharmacology to study and treat cancer
Oncodesign Services has a big collection of preclinical inflammatory and autoimmune models, covering diseases of the skin, gut, lungs, kidneys, liver and more
Oncodesign Services has BSL2 and BSL3 facilities and local partnerships allowing infectious disease models to be run
Oncodesign Services has developed translational skills and experience in this growing field to serve the evolving needs of R&D programs…
Get up to date with the latest Oncodesign Services developments and activities…
More than 230 emplyees are innovating and mobilizing their talents to contribute to the discovery of innovative therapies against cancers and serious diseases with high medical needs for its customers. Have a look how you could help!
OncodesignServices’ mission is to contribute to the discovery of innovative therapies that are effective against cancers and serious diseases with no known treatments.
News comes to you with regular newsletters and news, teeming with vitality and ingenuity!
Customers and partners, stay in the loop about our progress for our discoveries as well as new developments related to our service offers by subscribing to our newsletter at the heart of our Services activity.
20 rue Jean Mazen - FR - 21000 Dijon
Tel.+33 380 788 260
Receive our general news!
